Citation 38610

ONO,K: NAKANE,H: FUKUSHIMA,M: CHERMANN,JC: BARRE-SINOUSSI,F:. (1990). DIFFERENTIAL INHIBITION OF THE ACTIVITIES OF REVERSE TRANSCRIPTASE AND VARIOUS CELLAR DNA POLYMERASES BY A TRADITIONAL KAMPO DRUG, SHO-SAIKO-TO.. 44()

Citation Details

Title	DIFFERENTIAL INHIBITION OF THE ACTIVITIES OF REVERSE TRANSCRIPTASE AND VARIOUS CELLAR DNA POLYMERASES BY A TRADITIONAL KAMPO DRUG, SHO-SAIKO-TO.
Authors	ONO,K: NAKANE,H: FUKUSHIMA,M: CHERMANN,JC: BARRE-SINOUSSI,F:
Year	1990
Volume	44
Issue

Summary

Year: 1990

Journal: Unknown

Organisms and Their Experiments (7)

Bupleurum falcatum (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE BETA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	DNA POLYMERASE GAMMA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
3	DNA POLYMERASE ALPHA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Pinellia ternata (ARACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE BETA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	DNA POLYMERASE GAMMA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
3	DNA POLYMERASE ALPHA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Scutellaria baicalensis (LAMIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE BETA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	DNA POLYMERASE GAMMA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
3	DNA POLYMERASE ALPHA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Ziziphus jujuba (RHAMNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE BETA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	DNA POLYMERASE GAMMA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
3	DNA POLYMERASE ALPHA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Panax ginseng (ARALIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE BETA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	DNA POLYMERASE GAMMA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
3	DNA POLYMERASE ALPHA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Glycyrrhiza glabra (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE BETA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	DNA POLYMERASE GAMMA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
3	DNA POLYMERASE ALPHA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Zingiber officinale (ZINGIBERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE BETA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	DNA POLYMERASE GAMMA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
3	DNA POLYMERASE ALPHA INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Show SPARQL Queries (1)